Medicare Enrolled

Dr. Lance Sloan, MD

Nephrology · Lufkin, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
10 MEDICAL CENTER BLVD, Lufkin, TX 75904
9366324282
In practice since 2005 (20 years)
NPI: 1588665228 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sloan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sloan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sloan

Dr. Lance Sloan is a nephrology in Lufkin, TX, with 20 years in practice. Based on federal Medicare data, Dr. Sloan performed 2,556 Medicare services across 1,398 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sloan received a total of $1,798,072 from 74 pharmaceutical and/or device companies across 2777 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sloan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 17% volume in TX$ $1,798,072 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,556
Medicare services
Top 17% in TX for nephrology
1,398
Unique beneficiaries
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~128 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient, complex (40-54 min)687$121$295
Office visit, established patient (30-39 min)450$80$225
Office visit, established patient (20-29 min)282$55$155
Hemoglobin A1c test (diabetes monitoring)250$9$60
Hospital follow-up visit, high complexity232$89$220
Dialysis services, 4 or more physician visits per month (20 years or older)90$237$580
Drug injection, under skin or into muscle82$10$60
Initial hospital admission, high complexity71$130$415
Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use65$264$349
Pneumonia vaccine administration60$30$64
Influenza vaccine, quadrivalent derived from cell cultures56$32$45
Flu vaccine administration54$30$64
New patient office visit, complex (60-74 min)53$156$420
Hospital follow-up visit, moderate complexity46$60$155
New patient office visit (45-59 min)32$110$350
Office visit, established patient (10-19 min)28$30$95
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or18$25$117
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,798,072
Total received (2018-2024)
Avg $256,867/year across 7 years
Top 0% in TX for nephrology
74
Companies
2,777
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,627,214 (90.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$147,089 (8.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,769 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$359,587
2023
$182,296
2022
$127,706
2021
$202,742
2020
$172,407
2019
$456,968
2018
$296,367

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$613,598
Lilly USA, LLC
$296,139
Boehringer Ingelheim Pharmaceuticals, Inc.
$189,425
Janssen Pharmaceuticals, Inc
$188,084
Corcept Therapeutics
$112,148
Merck Sharp & Dohme Corporation
$102,736
Novo Nordisk Inc
$44,481
GlaxoSmithKline, LLC.
$42,657
PFIZER INC.
$35,855
Janssen Scientific Affairs, LLC
$19,777
SANOFI-AVENTIS U.S. LLC
$19,127
Bayer Healthcare Pharmaceuticals Inc.
$19,033
Eli Lilly and Company
$17,349
Abbott Laboratories
$12,642
Rockwell Medical, Inc.
$11,736
AbbVie, Inc.
$11,343
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$8,504
Ascendis Pharma Inc
$8,138
Novo Nordisk AS
$7,678
Boehringer Ingelheim International GmbH
$7,271
Bayer HealthCare Pharmaceuticals Inc.
$5,628
Travere Therapeutics, Inc.
$4,696
Gilead Sciences, Inc.
$4,598
Pfizer Inc.
$4,443
Medtronic MiniMed, Inc.
$1,839
Merck Sharp & Dohme LLC
$1,740
Amgen Inc.
$1,572
Amarin Pharma Inc.
$943
Dexcom, Inc.
$564
Radius Health, Inc.
$466
Xeris Pharmaceuticals, Inc.
$401
Novartis Pharmaceuticals Corporation
$396
Medtronic, Inc.
$333
Lexicon Pharmaceuticals, Inc.
$303
Esperion Therapeutics, Inc.
$202
Medicure Pharma Inc.
$199
Horizon Therapeutics plc
$132
Otsuka Pharmaceutical Development & Commercialization, Inc.
$123
Mylan Inc.
$120
Insulet Corporation
$116
IDORSIA PHARMACEUTICALS US INC
$108
Orexigen Therapeutics, Inc.
$107
Calliditas Therapeutics US Inc.
$105
Endo Pharmaceuticals Inc.
$80
Ultragenyx Pharmaceutical Inc.
$65
Kowa Pharmaceuticals America, Inc.
$64
Amryt Pharma Holdings Ltd
$62
Nevro Corp.
$62
Vifor Pharma, Inc.
$58
Fresenius USA Marketing, Inc.
$54
Tandem Diabetes Care, Inc.
$53
Covidien LP
$49
Relypsa, Inc.
$44
DEXCOM, INC.
$43
Takeda Pharmaceuticals U.S.A., Inc.
$43
ANI Pharmaceuticals, Inc.
$43
SCPHARMACEUTICALS INC.
$43
IBSA Pharma Inc.
$38
Allergan Inc.
$37
Intuity Medical Inc
$37
ABBVIE INC.
$35
GENZYME CORPORATION
$33
Shire North American Group Inc
$30
CorMedix Inc.
$28
Enterra Medical, Inc.
$27
Paratek Pharmaceuticals, Inc.
$25
RECORDATI_RARE_DISEASES_INC.
$23
Regeneron Healthcare Solutions, Inc.
$23
Supernus Pharmaceuticals, Inc.
$21
Kyowa Kirin, Inc.
$21
Alexion Pharmaceuticals, Inc.
$20
Otsuka America Pharmaceutical, Inc.
$20
Antares Pharma, Inc.
$19
Companion Medical, Inc.
$14
Top 3 companies account for 61.1% of total payments
Associated products mentioned in payments ›
AVEED · Aimovig · BAQSIMI · BELSOMRA · BENLYSTA · BREZTRI · BYDUREON · COMIRNATY · CONTRAVE · CYCLOSET · Crysvita · Cryvista · DEXCOM G6 TRANSMITTER · DefenCath · Dexcom G6 Transmitter · Dialyzers · ENTRESTO · EVENITY · FABRAZYME · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FUROSCIX · FreeStyle Libre 2 · FreeStyle Libre Pro · GVOKE HYPOPEN · GVOKE PFS · HMG-CoA reductase inhibitor. · HUMALOG · HUMULIN · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKAMET · INVOKANA · InPen · JANUVIA · JARDIANCE · JESDUVROQ · JYNARQUE · Kerendia · Korlym · LANTUS · LEQVIO · LICART · LOKELMA · Licart · Livalo · MINIMED 780G · MOUNJARO · MYALEPT · MYCAPSSA · Minimed 630G · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NUZYRA · Non-Covered · Norditropin · Omnia · Omnipod · Ozempic · PRALUENT · PREVNAR 13 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Parsabiv · Pogo Automatic Blood Glucose Monitoring System · Prolia · RECORLEV · RYBELSUS · Repatha · Rivfloza · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · SOTAGLIFLOZIN · STEGLATRO · STEGLUJAN · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Seglentis · Semglee · Senza · Situate · Skytrofa · Synthroid · TARPEYO · TAVNEOS · TEFLARO · TEPEZZA · TLANDO · TOUJEO · TRIFERIC · TRINTELLIX · TRULICITY · TZIELD · Tresiba · Tryvio · Tymlos · UBRELVY · Vascepa · Velphoro · Veltassa · Victoza · Wegovy · XARELTO · XYOSTED · ZEPBOUND · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in nephrology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for nephrology in TX.

Equivalent to $70,347 per 100 Medicare services performed
Looking for a nephrology in Lufkin?
Compare nephrologys in the Lufkin area by procedure volume, costs, and industry payment transparency.
Browse nephrologys nearby

Geographic Context

Nephrologys within 10 mi
1
Per 100K population
1.2
County median income
$58,847
Nearest hospital
WOODLAND HEIGHTS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sloan is a clinical cardiology specialist, with above-average Medicare volume (top 17% in TX), and high industry engagement (speaking/promotional, top 0%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sloan experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Sloan performed 687 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sloan receive payments from pharmaceutical companies?
Yes. Dr. Sloan received a total of $1,798,072 from 74 companies across 2,777 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sloan's costs compare to other nephrologys in Lufkin?
Dr. Sloan's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sloan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →